More on TEM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $48.79 |
|
|||
| Open | $48.79 | ||||
| 52 Wk High | $0.45 | ||||
| 52 Wk Low | $0.37 | ||||
| Day High | $48.79 | ||||
| Day Low | $48.79 | ||||
| P/E | N/A | ||||
| EPS | $-0.31 | ||||
| Volume | 81,086 | ||||
- Tempus publishes validation study for FDA-cleared ECG AI model
- Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
- TD Cowen notes short interest shifts in life science tools stocks
- Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
- Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Form 4 Tempus AI, Inc. For: Jun 01 Filed by: Epstein David R
- Tempus launches open-source digital pathology consortium with Yale, MSK
- Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
- Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
- Wolfe Research Assumes Tempus AI Inc (TEM) at Peerperform
Entities mentioned with TEM
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- James Beeland Rogers Jr. | View Related Stories »
- Twitter | View Related Stories »
- Show More...
